Cingulate Inc. (CING) stock

CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30

$4.49−0.15 (-3.23%)

Close on Nov 12, 2026Market cap $65.29MP/E –Yield –

Cingulate revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Cingulate has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?